U.S., Sept. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07182864) titled 'MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis' on Sept. 12.
Brief Summary: This is a Phase I/II Study of MH004 in Healthy Adult Volunteers, participants with Mild to Moderate Atopic Dermatitis.
Study Start Date: Jan. 06, 2022
Study Type: INTERVENTIONAL
Condition:
Atopic Dermatitis (AD)
Intervention:
DRUG: MH004 0.1% Ointment
MH004 0.1% ointment applied topically to the affected area as a thin film.
DRUG: MH004 0.3% Ointment
MH004 0.3% ointment applied topically to the affected area as a thin film.
DRUG: MH004 1.0% Ointment
MH004 1.0% ointment applied topically to the ...